Accretive Health (AH +4.1%) outperforms after UBS starts the company at Outperoform. The firm...


Accretive Health (AH +4.1%) outperforms after UBS starts the company at Outperoform. The firm touts the ability of Accretive's revenue management services to improve hospital margins, and sees its penetration rate rising to 5% by 2014, from a current 2%. UBS also believes new services offerings are ramping ahead of expectations.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs